Learn more about Peter Attia’s digital program
First anti-inflammatory medication approved for treatment of ASCVD
Low-dose colchicine, an anti-inflammatory drug, was recently approved by the FDA to reduce risk of cardiovascular events
Ketamine-Assisted Therapy: A Promising Approach for Treating Depression and Anxiety?
A recent study investigated the safety and effectiveness of at-home ketamine-assisted therapy for the treatment of depression and anxiety.
A case study on the importance of taking charge of one’s own health
The personal story of a podcast listener who sought to gain a better picture of his cardiovascular health – and who saved his own life as a result.
The Drive Turns Five
A pitstop to look back on the last five years and forward to the road ahead
Taurine improves the health and longevity of mice and monkeys – but what about humans?
A new study set off a media storm over taurine’s potential in delaying aging and extending lifespan. Great news – if you’re a mouse.
Cumulative time spent in “vigorous” physical activity lowers mortality risk
But the effects of frequent, sub-minute bouts of high-intensity movement have not convinced me to change my exercise routine.
Does carbohydrate load impact the balance between fat storage and oxidation?
A study investigated the effects of different dietary levels of carbohydrates on mitochondrial respiration, but mechanistic conclusions are premature.
Separating substance from nonsense in a study on NMN supplements
A recent randomized trial investigated the effect of NMN supplementation on NAD levels, biological aging, and exercise performance. What can we believe from their results?
“The cholesterol paradox”: a catchy phrase for an idea with no substance
A recent study reported that hypercholesterolemia is associated with reduced mortality, but it falls short of upsetting conventional wisdom
Clearing the air on hormone replacement therapy
My recent podcast with Dr. JoAnn Manson evidently raised as many questions about HRT as it answered, so let’s take a closer look at the evidence for risks and benefits.